Platinum Sponsors
Dr. Falk Pharma
As a research-based family business with global presence, we focus on the development and distribution of innovative medicines that improve patients’ health and well-being. For over 60 years.
Sanofi Regeneron
We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our teams across the world strive to transform the practice of medicine, turning the impossible into the possible for patients.
Bristol Myers Squibb
Bristol Myers Squibb is a differentiated company, led by our unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm.
Alimentiv
We are a niche GI contract research organization. At Alimentiv we foster innovation in health care by investing profits back into R&D, identifying novel solutions to unmet needs, engaging talented people and providing them with the resources to succeed.
AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide..
Gold Sponsors
Allakos
We are a clinical stage biotechnology company developing therapeutic antibodies to treat allergic, inflammatory and proliferative diseases. We create monoclonal antibodies that activate or block inhibitory receptors on immune cells. Activating inhibitory receptors allows us to directly inhibit cells involved in disease pathogenesis and, in the setting of allergy and inflammation, has the potential to reduce inflammation.
EsoCap AG
EsoCap’s vision is to improve the lives of patients affected by esophageal diseases. The esophagus is a particularly challenging environment, as swallowed drugs only remain in the area between the mouth and the stomach for a few seconds. EsoCap has developed a novel solution designed to provide targeted and long-lasting local therapy in the upper gastrointestinal tract.
Sponsor
Aquilion
Aqilion is a Swedish biopharma company that develops innovative new therapies for diseases caused by chronic inflammation and dysfunctional immune reactions.
